Latest p/e ratio

BridgeBio Oncology Therapeutics P/E ratio

Direct answer

BridgeBio Oncology Therapeutics's p/e ratio is 4.04x.

The verified market snapshot reports 4.04x.
Bullstory displays the reported value and does not estimate missing data.
Market data checked November 15, 2026.

Get free BridgeBio Oncology Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

P/E ratio
4.04x